Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
Khattab
Taha M
TM
Department of Pediatric Oncology/Hematology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Jeddah, Kingdom of Saudi Arabia. khattabt@hotmail.com
Atra
Ayad A
AA
Elimam
Najla A
NA
Kassar
Ahmed
A
Zayed
Abdullah
A
Baothman
Abdullah
A
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D012189:Retrospective Studies; D012529:Saudi Arabia / Q000453:epidemiology; D015996:Survival Rate; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
D003561:Cytarabine; D005047:Etoposide; D004317:Doxorubicin; D014740:Vidarabine; C024352:fludarabine